Risk factors for cardiovascular disease in women with diabetes

Gender Medicine

Volumn 7, Issue 6, 2010, Pages 551-556

  Maric, Christine ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ESTROGEN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ESTROGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART PROTECTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN TREATMENT; MENOPAUSE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 78650888304     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2010.11.007     Document Type: Editorial

References (66)

1. CS Fox, S Coady, and PD Sorlie Trends in cardiovascular complications of diabetes JAMA 292 2004 2495 2499
2. SR Preis, SJ Hwang, and S Coady Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005 Circulation 119 2009 1728 1735
3. S Allemann, C Saner, and M Zwahlen Long-term cardiovascular and non-cardiovascular mortality in women and men with type 1 and type 2 diabetes mellitus: A 30-year follow-up in Switzerland Swiss Med Wkly. 139 2009 576 583
4. WB Kannel, and DL McGee Diabetes and cardiovascular disease. The Framingham study JAMA 241 1979 2035 2038
5. HL Hillege, V Fidler, GF Diercks Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 2002 1777 1782
6. D de Zeeuw, HH Parving, and RH Henning Micro-albuminuria as an early marker for cardiovascular disease J Am Soc Nephrol. 17 2006 2100 2105
7. AC Dale, LJ Vatten, and TI Nilsen Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: Cohort study BMJ 337 2008 a236
8. EW Gregg, Q Gu, and YJ Cheng Mortality trends in men and women with diabetes, 1971 to 2000 Ann Intern Med. 147 2007 149 155
9. E Barrett-Connor, KE Ensrud, and K Harper Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes Clin Ther. 25 2003 919 930
10. CL Morgan, CJ Currie, and JR Peters Relationship between diabetes and mortality: A population study using record linkage Diabetes Care 23 2000 1103 1107
11. SI Dawson, J Willis, CM Florkowski, and RS Scott Cause-specific mortality in insulin-treated diabetic patients: A 20-year follow-up Diabetes Res Clin Pract. 80 2008 16 23
12. A Szalat, and I Raz Gender-specific care of diabetes mellitus: Particular considerations in the management of diabetic women [published correction appears in Diabetes Obes Metab. 2009;11:76] Diabetes Obes Metab. 10 2008 1135 1156
13. AS Krolewski, A Czyzyk, D Janeczko, and J Kopczynski Mortality from cardiovascular diseases among diabetics Diabetologia 13 1977 345 350
14. SR Preis, MJ Pencina, and SJ Hwang Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study Circulation 120 2009 212 220
15. SP Laing, AJ Swerdlow, and SD Slater Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes Diabetologia 46 2003 760 765
16. JS Dorman, RE Laporte, and LH Kuller The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results Diabetes 33 1984 271 276
17. T Skrivarhaug, HJ Bangstad, and LC Stene Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway Diabetologia 49 2006 298 305
18. I Waernbaum, G Blohme, and J Ostman Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: A population-based study (DISS) in Sweden [published correction appears in Diabetologia. 2006;49:1457] Diabetologia 49 2006 653 659
19. B Berger, G Stenstrom, and G Sundkvist Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry Diabetes Care 22 1999 773 778
20. CS Gbl, W Brannath, and L Bozkurt Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus Gend Med. 7 2010 593 599
21. PC Yu, Z Bosnyak, and A Ceriello The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes Diabetes Res Clin Pract. 89 2010 1 9
22. L Nalysnyk, M Hernandez-Medina, and G Krishnarajah Glycaemic variability and complications in patients with diabetes mellitus: Evidence from a systematic review of the literature Diabetes Obes Metab. 12 2010 288 298
23. E Barrett-Connor, EG Giardina, and AK Gitt Women and heart disease: The role of diabetes and hyperglycemia Arch Intern Med. 164 2004 934 942 (Pubitemid 38581511)
24. M Laakso Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes Prim Care 26 1999 829 839 (Pubitemid 29523602)
25. DJ Wexler, RW Grant, and JB Meigs Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes Diabetes Care 28 2005 514 520
26. E Barrett-Connor, and A Ferrara Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study Diabetes Care 21 1998 1236 1239
27. M Wei, SP Gaskill, SM Haffner, and MP Stern Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study Diabetes Care 21 1998 1167 1172
28. C Le May, K Chu, and M Hu Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice Proc Natl Acad Sci U S A 103 2006 9232 9237
29. N Yamabe, KS Kang, and BT Zhu Beneficial effect of 17β-estradiol on hyperglycemia and islet β-cell functions in a streptozotocin-induced diabetic rat model Toxicol Appl Pharmacol. 249 2010 76 85
30. AM Kanaya, D Herrington, E Vittinghoff Heart and Estrogen/progestin Replacement Study Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial Ann Intern Med. 138 2003 1 9
31. KL Margolis, DE Bonds, RJ Rodabough Women's Health Initiative Investigators Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: Results from the Women's Health Initiative Hormone Trial Diabetologia 47 2004 1175 1187
32. KE Stamataki, J Spina, and DB Rangou Ovarian function in women with non-insulin dependent diabetes mellitus Clin Endocrinol (Oxf) 45 1996 615 621
33. EL Ding, Y Song, VS Malik, and S Liu Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis JAMA 295 2006 1288 1299
34. A Juutilainen, S Kortelainen, and S Lehto Gender difference in the impact of type 2 diabetes on coronary heart disease risk Diabetes Care 27 2004 2898 2904
35. JG O'Meara, SL Kardia, and JJ Armon Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study Arch Intern Med. 164 2004 1313 1318
36. RM Bergenstal, C Wysham, L Macconell DURATION-2 Study Group Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): A randomised trial Lancet 376 2010 431 439
37. S Fazio, JR Guyton, and AB Polis Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia Am J Cardiol. 105 2010 487 494
38. M Farnier, J Ducobu, and L Bryniarski Efficacy and safety of adding fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by pravastatin 40 mg monotherapy Am J Cardiol. 106 2010 787 792
39. JW Blasetto, EA Stein, and WV Brown Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups Am J Cardiol. 91 2003 3C 10C
40. JW Blasetto, EA Stein, and WV Brown Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups Am J Cardiol. 91 2003 10C
41. MS Gowri, DR Van der Westhuyzen, SR Bridges, and JW Anderson Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL Arterioscler Thromb Vasc Biol. 19 1999 2226 2233
42. JJ Mourad, and S Le Jeune Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 Years of progress J Hypertens Suppl. 26 2008 S7 S13
43. F Turnbull, B Neal, C Algert Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: Results of prospectively designed overviews of randomized trials Arch Intern Med. 165 2005 1410 1419
44. P Gaede, P Vedel, and N Larsen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med. 348 2003 383 393 (Pubitemid 36159355)
45. LH Lindholm, H Ibsen, B Dahlof LIFE Study Group Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol Lancet 359 2002 1004 1010 (Pubitemid 34286537)
46. PM Nilsson, H Theobald, G Journath, and T Fritz Gender differences in risk factor control and treatment profile in diabetes: A study in 229 Swedish primary health care centres Scand J Prim Health Care 22 2004 27 31
47. Hypertension in Diabetes Study (HDS): I Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications J Hypertens 11 1993 309 317
48. KL Ong, BM Cheung, and YB Man Prevalence, awareness, treatment, and control of hypertension among United States adults 19992004 Hypertension 49 2007 69 75
49. RS Vasan, A Beiser, and S Seshadri Residual life-time risk for developing hypertension in middleaged women and men: The Framingham Heart Study JAMA 287 2002 1003 1010
50. S Lewington, R Clarke, N Qizilbash Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies [published correction appears in Lancet. 2003;361:1060] Lancet 360 2002 1903 1913
51. H Shi, and DJ Clegg Sex differences in the regulation of body weight Physiol Behav. 97 2009 199 204
52. TP Nedungadi, and DJ Clegg Sexual dimorphism in body fat distribution and risk for cardiovascular diseases J Cardiovasc Transl Res. 2 2009 321 327
53. V Regitz-Zagrosek, E Lehmkuhl, and S Mahmoodzadeh Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease Gend Med. 4 Suppl B 2007 S162 S177
54. MB Olson, LJ Shaw, EE Kaizar WISE Study Group Obesity distribution and reproductive hormone levels in women: A report from the NHLBI-sponsored WISE Study J Womens Health (Larchmt) 15 2006 836 842
55. ME Mendelsohn Estrogen actions in the cardiovascular system Climacteric 12 Suppl 1 2009 18 21
56. C Vitale, ME Mendelsohn, and GM Rosano Gender differences in the cardiovascular effect of sex hormones Nat Rev Cardiol. 6 2009 532 542
57. SP Duckles, and VM Miller Hormonal modulation of endothelial NO production Pflugers Arch. 459 2010 841 851
58. RK Dubey, S Oparil, B Imthurn, and EK Jackson Sex hormones and hypertension Cardiovasc Res. 53 2002 688 708
59. S Lamon-Fava, JB Barnett, and MN Woods Differences in serum sex hormone and plasma lipid levels in Caucasian and African-American premenopausal women J Clin Endocrinol Metab. 90 2005 4516 4520
60. A Cignarella, C Bolego, and C Pinna The influence of sex hormones on vascular responses in the aorta of streptozotocin-diabetic male rats Naunyn Schmiedebergs Arch Pharmacol. 361 2000 514 520
61. A Ferrara, AJ Karter, LM Ackerson Northern California Kaiser Permanente Diabetes Registry Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry Diabetes Care 24 2001 1144 1150
62. K Samaras, CS Hayward, and D Sullivan Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: A prospective study Diabetes Care 22 1999 1401 1407
63. VK Khor, R Dhir, and X Yin Estrogen sulfotrans-ferase regulates body fat and glucose homeostasis in female mice Am J Physiol Endocrinol Metab. 299 2010 E657 E664
64. M Yepuru, J Eswaraka, and JD Kearbey Estrogen receptor-beta-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice J Biol Chem. 285 2010 31292 31303
65. LM Brown, and DJ Clegg Central effects of estradiol in the regulation of food intake, body weight, and adiposity J Steroid Biochem Mol Biol. 122 2010 65 73
66. C Maric, and S Sullivan Estrogens and the diabetic kidney Gend Med. 5 Suppl A 2008 S103 S113